Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Roles of FcRn in Antigen-Presenting Cells during Autoimmunity and a Clinical Evaluation of Efgartigimod as an FcRn Blocker

Zhou Y. and Jiang S., (2023), Pathogens, 12, 817 - 817

Editorial: Peptide-based immunotherapy against emerging viral infections.

Jiang S., (2023), Front Immunol, 14

HIV associated cell death: Peptide-induced apoptosis restricts viral transmission.

Chen Q. et al, (2023), Front Immunol, 14

Survivin-Based Recombinant Overlapping Peptides Induce T Lymphocyte Cytotoxicity and Prolong the Survival in In Vivo Melanoma Model

Zhang Y. et al, (2023), Advanced Therapeutics

Editorial: Research, Development and Clinical Trials for Peptide-Based Vaccines.

Jiang S. et al, (2022), Front Immunol, 13

In Vitro and In Vivo Antigen Presentation and Diagnosis Development of Recombinant Overlapping Peptides Corresponding to Mtb ESAT-6/CFP-10.

Zhang Q. et al, (2022), Front Immunol, 13

Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines

Stephens AJ. et al, (2021), Frontiers in Immunology, 12

Survivin as a Biological Biomarker for Diagnosis and Therapy.

Li Y. et al, (2021), Expert Opin Biol Ther

HPV-16 E7-Specific Cellular Immune Response in Women With Cervical Intraepithelial Lesion Contributes to Viral Clearance: A Cross-Sectional and Longitudinal Clinical Study.

Zhang L. et al, (2021), Front Immunol, 12

TNF-derived peptides inhibit tumour growth and metastasis through cytolytic effects on tumour lymphatics.

Lu W. et al, (2019), Clin Exp Immunol

ANTIBODY FACILITATING PROGRAMMED NECROSIS OF CELLS AND APPLICATION THEREOF

JIANG S. and Lu W., (2018)

PROTEIN FOR NEUTRALIZING PROGRAMMED NECROCYTOSIS PROMOTION ANTIBODY, AND APPLICATION OF PROTEIN

JIANG S. and Lu W., (2018)

Protective cellular immunity generated by cross-presenting recombinant overlapping peptide proteins.

Cai L. et al, (2017), Oncotarget, 8, 76516 - 76524

ARTIFICIAL MULTI-ANTIGEN FUSION PROTEIN AND PREPARATION AND USE THEREOF

JIANG S. et al, (2017)

A DC vaccine and its preparation method and applications

Weixing S. et al, (2014)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy

Tchilian E. et al, (2013), Vaccine, 31, 4624 - 4631

Overlapping peptides taken as reagents for skin tests detecting specific cellular immune and applications

JIANG S., (2013)

TNF-alpha short peptide- related to apoptosis or necrosis and applications thereof

JIANG S., (2012)

Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in a murine mammary breast cancer model.

Hong H. et al, (2010), Clin Exp Immunol, 159, 93 - 99

Comparing pooled peptides with intact protein for accessing cross-presentation pathways for protective CD8+ and CD4+ T cells.

Zhang H. et al, (2009), J Biol Chem, 284, 9184 - 9191

Load More